Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2000 May 4;66(6):1757–1765. doi: 10.1086/302933

Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).

U Schwarze 1, M Atkinson 1, G G Hoffman 1, D S Greenspan 1, P H Byers 1
PMCID: PMC1378060  PMID: 10796876

Abstract

Ehlers-Danlos syndrome (EDS) types I and II, which comprise the classical variety, are well characterized from the clinical perspective, but it has been difficult to identify the molecular basis of the disorder in the majority of affected individuals. Several explanations for this failure to detect mutations have been proposed, including genetic heterogeneity, failure of allele expression, and technical difficulties. Genetic heterogeneity has been confirmed as an explanation for such failure, since causative mutations have been identified in the COL5A1, COL5A2, and tenascin X genes and since they have been inferred in the COL1A2 gene. Nonetheless, in the majority of families with autosomal dominant inheritance of EDS, there appears to be linkage to loci that contain the COL5A1 or COL5A2 genes. To determine whether allele-product instability could explain failure to identify some mutations, we analyzed polymorphic variants in the COL5A1 gene in 16 individuals, and we examined mRNA for the expression of both alleles and for alterations in splicing. We found a splice-site mutation in a single individual, and we determined that, in six individuals, the mRNA from one COL5A1 allele either was not expressed or was very unstable. We identified small insertions or deletions in five of these cell strains, but we could not identify the mutation in the sixth individual. Thus, although as many as one-half of the mutations that give rise to EDS types I and II are likely to lie in the COL5A1 gene, a significant portion of them result in very low levels of mRNA from the mutant allele, as a consequence of nonsense-mediated mRNA decay.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beighton P., De Paepe A., Steinmann B., Tsipouras P., Wenstrup R. J. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998 Apr 28;77(1):31–37. doi: 10.1002/(sici)1096-8628(19980428)77:1<31::aid-ajmg8>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  2. Birk D. E., Fitch J. M., Babiarz J. P., Linsenmayer T. F. Collagen type I and type V are present in the same fibril in the avian corneal stroma. J Cell Biol. 1988 Mar;106(3):999–1008. doi: 10.1083/jcb.106.3.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bonadio J., Holbrook K. A., Gelinas R. E., Jacob J., Byers P. H. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem. 1985 Feb 10;260(3):1734–1742. [PubMed] [Google Scholar]
  4. Burch G. H., Gong Y., Liu W., Dettman R. W., Curry C. J., Smith L., Miller W. L., Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet. 1997 Sep;17(1):104–108. doi: 10.1038/ng0997-104. [DOI] [PubMed] [Google Scholar]
  5. Burrows N. P., Nicholls A. C., Richards A. J., Luccarini C., Harrison J. B., Yates J. R., Pope F. M. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am J Hum Genet. 1998 Aug;63(2):390–398. doi: 10.1086/301948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burrows N. P., Nicholls A. C., Yates J. R., Gatward G., Sarathachandra P., Richards A., Pope F. M. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. J Invest Dermatol. 1996 Jun;106(6):1273–1276. doi: 10.1111/1523-1747.ep12348978. [DOI] [PubMed] [Google Scholar]
  7. Burrows N. P., Nicholls A. C., Yates J. R., Richards A. J., Pope F. M. Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes. Clin Exp Dermatol. 1997 Jul;22(4):174–176. [PubMed] [Google Scholar]
  8. Cappa F., Caridi G., Gimelli G., Ghiggeri G. M. A new biallelic DNA polymorphism of the human COL5A1 gene. Hum Genet. 1995 May;95(5):599–600. doi: 10.1007/BF00223882. [DOI] [PubMed] [Google Scholar]
  9. De Paepe A., Nuytinck L., Hausser I., Anton-Lamprecht I., Naeyaert J. M. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet. 1997 Mar;60(3):547–554. [PMC free article] [PubMed] [Google Scholar]
  10. Emanuel B. S., Cannizzaro L. A., Seyer J. M., Myers J. C. Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2. Proc Natl Acad Sci U S A. 1985 May;82(10):3385–3389. doi: 10.1073/pnas.82.10.3385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Frischmeyer P. A., Dietz H. C. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet. 1999;8(10):1893–1900. doi: 10.1093/hmg/8.10.1893. [DOI] [PubMed] [Google Scholar]
  12. Grahame R., Beighton P. Physical properties of the skin in the Ehlers-Danlos syndrome. Ann Rheum Dis. 1969 May;28(3):246–251. doi: 10.1136/ard.28.3.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Greenspan D. S., Cheng W., Hoffman G. G. The pro-alpha 1(V) collagen chain. Complete primary structure, distribution of expression, and comparison with the pro-alpha 1(XI) collagen chain. J Biol Chem. 1991 Dec 25;266(36):24727–24733. [PubMed] [Google Scholar]
  14. Greenspan D. S., Northrup H., Au K. S., McAllister K. A., Francomano C. A., Wenstrup R. J., Marchuk D. A., Kwiatkowski D. J. COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II. Genomics. 1995 Feb 10;25(3):737–739. doi: 10.1016/0888-7543(95)80021-d. [DOI] [PubMed] [Google Scholar]
  15. Greenspan D. S., Pasquinelli A. E. BstUI and DpnII RFLPs at the COL5A1 gene. Hum Mol Genet. 1994 Feb;3(2):385–385. doi: 10.1093/hmg/3.2.385-a. [DOI] [PubMed] [Google Scholar]
  16. Haralson M. A., Mitchell W. M., Rhodes R. K., Kresina T. F., Gay R., Miller E. J. Chinese hamster lung cells synthesize and confine to the cellular domain a collagen composed solely of B chains. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5206–5210. doi: 10.1073/pnas.77.9.5206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hata R., Kurata S., Shinkai H. Existence of malfunctioning pro alpha2(I) collagen genes in a patient with a pro alpha 2(I)-chain-defective variant of Ehlers-Danlos syndrome. Eur J Biochem. 1988 Jun 1;174(2):231–237. doi: 10.1111/j.1432-1033.1988.tb14087.x. [DOI] [PubMed] [Google Scholar]
  18. Hausser I., Anton-Lamprecht I. Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification. Hum Genet. 1994 Apr;93(4):394–407. doi: 10.1007/BF00201664. [DOI] [PubMed] [Google Scholar]
  19. Holbrook K. A., Byers P. H. Skin is a window on heritable disorders of connective tissue. Am J Med Genet. 1989 Sep;34(1):105–121. doi: 10.1002/ajmg.1320340118. [DOI] [PubMed] [Google Scholar]
  20. Kumamoto C. A., Fessler J. H. Biosynthesis of A,B procollagen. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6434–6438. doi: 10.1073/pnas.77.11.6434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Linsenmayer T. F., Gibney E., Igoe F., Gordon M. K., Fitch J. M., Fessler L. I., Birk D. E. Type V collagen: molecular structure and fibrillar organization of the chicken alpha 1(V) NH2-terminal domain, a putative regulator of corneal fibrillogenesis. J Cell Biol. 1993 Jun;121(5):1181–1189. doi: 10.1083/jcb.121.5.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Loughlin J., Irven C., Hardwick L. J., Butcher S., Walsh S., Wordsworth P., Sykes B. Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II). Hum Mol Genet. 1995 Sep;4(9):1649–1651. doi: 10.1093/hmg/4.9.1649. [DOI] [PubMed] [Google Scholar]
  23. Maquat L. E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA. 1995 Jul;1(5):453–465. [PMC free article] [PubMed] [Google Scholar]
  24. McCarthy E. M., Phillips J. A., 3rd Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum Mol Genet. 1998 Sep;7(9):1491–1496. doi: 10.1093/hmg/7.9.1491. [DOI] [PubMed] [Google Scholar]
  25. McCullough A. J., Berget S. M. G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol Cell Biol. 1997 Aug;17(8):4562–4571. doi: 10.1128/mcb.17.8.4562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Michalickova K., Susic M., Willing M. C., Wenstrup R. J., Cole W. G. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. Hum Mol Genet. 1998 Feb;7(2):249–255. doi: 10.1093/hmg/7.2.249. [DOI] [PubMed] [Google Scholar]
  27. Moradi-Améli M., Rousseau J. C., Kleman J. P., Champliaud M. F., Boutillon M. M., Bernillon J., Wallach J., Van der Rest M. Diversity in the processing events at the N-terminus of type-V collagen. Eur J Biochem. 1994 May 1;221(3):987–995. doi: 10.1111/j.1432-1033.1994.tb18815.x. [DOI] [PubMed] [Google Scholar]
  28. Nicholls A. C., Oliver J. E., McCarron S., Harrison J. B., Greenspan D. S., Pope F. M. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. J Med Genet. 1996 Nov;33(11):940–946. doi: 10.1136/jmg.33.11.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Niyibizi C., Fietzek P. P., van der Rest M. Human placenta type V collagens. Evidence for the existence of an alpha 1(V) alpha 2(V) alpha 3(V) collagen molecule. J Biol Chem. 1984 Nov 25;259(22):14170–14174. [PubMed] [Google Scholar]
  30. Rhodes R. K., Miller E. J. Evidence for the existence of an alpha 1(V) alpha 2(V) alpha 3(V) collagen molecule in human placental tissue. Coll Relat Res. 1981 Jul;1(4):337–343. doi: 10.1016/s0174-173x(81)80010-6. [DOI] [PubMed] [Google Scholar]
  31. Richards A. J., Martin S., Nicholls A. C., Harrison J. B., Pope F. M., Burrows N. P. A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II. J Med Genet. 1998 Oct;35(10):846–848. doi: 10.1136/jmg.35.10.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sasaki T., Arai K., Ono M., Yamaguchi T., Furuta S., Nagai Y. Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen. Arch Dermatol. 1987 Jan;123(1):76–79. doi: 10.1001/archderm.123.1.76. [DOI] [PubMed] [Google Scholar]
  33. Schwarze U., Starman B. J., Byers P. H. Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. Am J Hum Genet. 1999 Aug;65(2):336–344. doi: 10.1086/302512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Smith L. T., Wertelecki W., Milstone L. M., Petty E. M., Seashore M. R., Braverman I. M., Jenkins T. G., Byers P. H. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. Am J Hum Genet. 1992 Aug;51(2):235–244. [PMC free article] [PubMed] [Google Scholar]
  35. Sokolov B. P., Prytkov A. N., Tromp G., Knowlton R. G., Prockop D. J. Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family. Hum Genet. 1991 Dec;88(2):125–129. doi: 10.1007/BF00206058. [DOI] [PubMed] [Google Scholar]
  36. Takahara K., Hoffman G. G., Greenspan D. S. Complete structural organization of the human alpha 1 (V) collagen gene (COL5A1): divergence from the conserved organization of other characterized fibrillar collagen genes. Genomics. 1995 Oct 10;29(3):588–597. doi: 10.1006/geno.1995.9961. [DOI] [PubMed] [Google Scholar]
  37. Toriello H. V., Glover T. W., Takahara K., Byers P. H., Miller D. E., Higgins J. V., Greenspan D. S. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet. 1996 Jul;13(3):361–365. doi: 10.1038/ng0796-361. [DOI] [PubMed] [Google Scholar]
  38. Truter S., Andrikopoulos K., Di Liberto M., Womack L., Ramirez F. Pro-alpha 2(V) collagen gene; pairwise analysis of the amino-propeptide coding domain, and cross-species comparison of the promoter sequence. Connect Tissue Res. 1993;29(1):51–59. doi: 10.3109/03008209309061966. [DOI] [PubMed] [Google Scholar]
  39. Vogel A., Holbrook K. A., Steinmann B., Gitzelmann R., Byers P. H. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest. 1979 Feb;40(2):201–206. [PubMed] [Google Scholar]
  40. Weil D., Bernard M., Gargano S., Ramirez F. The pro alpha 2(V) collagen gene is evolutionarily related to the major fibrillar-forming collagens. Nucleic Acids Res. 1987 Jan 12;15(1):181–198. doi: 10.1093/nar/15.1.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wenstrup R. J., Langland G. T., Willing M. C., D'Souza V. N., Cole W. G. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet. 1996 Nov;5(11):1733–1736. doi: 10.1093/hmg/5.11.1733. [DOI] [PubMed] [Google Scholar]
  42. Wordsworth B. P., Ogilvie D. J., Sykes B. C. Segregation analysis of the structural genes of the major fibrillar collagens provides further evidence of molecular heterogeneity in type II Ehlers-Danlos syndrome. Br J Rheumatol. 1991 Jun;30(3):173–177. doi: 10.1093/rheumatology/30.3.173. [DOI] [PubMed] [Google Scholar]
  43. Wordsworth P., Ogilvie D., Smith R., Sykes B. Exclusion of the alpha 1(II) collagen structural gene as the mutant locus in type II Ehlers-Danlos syndrome. Ann Rheum Dis. 1985 Jul;44(7):431–433. doi: 10.1136/ard.44.7.431. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES